Table 2. Comparison of patients on aspirin in the arthroplasty studies with the number and rates of VTE.
Study author | Dose of aspirin | Length of treatment | Number of patients on aspirin | Number of patients who suffered from symptomatic DVT | Rate of symptomatic DVT |
---|---|---|---|---|---|
Raphael et al, 2014 15 | 325 mg BD | Unknown | 2,800 | 8 | 0.29% |
Jiang et al, 2014 16 | ? | ? | 60 | 0 | 0.00% |
Zou et al, 2014 17 | 100 mg/d | 14 d | 110 | 2 | 1.81% |
Na et al, 2015 18 | 100 mg/d | 14 d | 282 | 0 | 0.00% |
Pow and Vale, 2015 20 | Unknown | Minimum 10–14 d | 125 | 4 | 3.20% |
Ogonda et al, 2016 21 | 150 mg OD | 6 wk | 11,459 | 37 | 0.32% |
Yhim et al, 2017 22 | Unknown | On average for 9 d | 28,176 | 232 | 0.82% |
Total | − | − | 43,012 | 283 | 0.66% |
Abbreviations: BD, twice a day; DVT, deep vein thrombosis; OD, once daily; VTE, venous thromboembolism.